Waltham, 2451, MA,
United States
Oncopeptides, Inc. Technographics
Oncopeptides, Inc. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Oncopeptides, Inc. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 88 Oncopeptides, Inc. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Oncopeptides, Inc. has purchased the following applications: Veeva Oncology Link for Analytics and BI in 2020, Microsoft 365 for Collaboration in 2018, Oracle Moat for Marketing Analytics in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Oncopeptides, Inc. is running and its propensity to invest more and deepen its relationship with Veeva Systems , Microsoft , Oracle or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Oncopeptides, Inc. revenues, which have grown to $7.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Oncopeptides, Inc. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Oncopeptides, Inc. Tech Stack and Enterprise Applications
Oncopeptides, Inc. Analytics and BI
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Veeva Systems | Legacy | Veeva Oncology Link | Analytics and BI | Analytics and BI | n/a | 2020 | 2020 |
In 2020, Oncopeptides, Inc. implemented Veeva Oncology Link to centralize oncology-specific intelligence for its commercial organization. Veeva Oncology Link is used as an Analytics and BI application to deliver curated intelligence on people, institutions, and developments across the oncology healthcare community, supporting field engagement and strategic sales analytics.
The deployment consolidated clinician and institutional profiles, research and clinical development signals, and outreach intelligence into a single access layer for field teams and the sales analytics function. Configuration emphasized data access and role-based delivery for field users, with sales analytics responsible for operational oversight and content curation. Oncopeptides, Inc. Veeva Oncology Link Analytics and BI relationships focus on enabling field engagement workflows and supporting sales analytics reporting, with users reporting that the solution provides intelligence on people, institutions, and developments all in one place.
|
Oncopeptides, Inc. Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2018 | 2018 |
In 2018, Oncopeptides, Inc. implemented Microsoft 365. Microsoft 365 is deployed as the company’s Collaboration platform and is referenced on Oncopeptides’ public website. The implementation supports core business functions for a life sciences organization of about 88 employees in the United States, concentrating on office productivity, document management, and team communication. Oncopeptides, Inc. Microsoft 365 Collaboration supports internal collaboration and content surfaced externally on the corporate site.
The deployment architecture aligns with cloud SaaS tenancy models typical for Collaboration suites, centralizing user identity and document repositories to enable shared workspaces and site content publishing. Functional capabilities aligned with Microsoft 365 Collaboration include cloud email and calendaring, document co-authoring, intranet site hosting, and collaboration workflows, which address research administration and corporate communications needs. Governance elements such as access control, information architecture, and content publishing workflows are consistent controls applied to this class of Collaboration deployments.
|
Oncopeptides, Inc. CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle Moat | Marketing Analytics | CRM | n/a | 2021 | 2021 |
In 2021, Oncopeptides, Inc. deployed Oracle Moat on their website. Oracle Moat is being used as a Marketing Analytics application to instrument the corporate web property for digital advertising measurement, focusing on viewability, attention metrics, and ad verification capabilities typical of the category. The implementation uses site-level script tagging to capture exposure and engagement signals, and the Oracle Moat deployment is framed to support marketing and digital advertising workflows rather than broad enterprise analytics. Oncopeptides, Inc. Oracle Moat Marketing Analytics outputs are routed into marketing operations for campaign analysis and creative validation.
Deployment scope is limited to the company website serving the United States, with operational responsibility aligned to marketing and demand generation functions. Governance centers on tag deployment controls and consent management at the site level, and configuration emphasizes the measurement modules common to Marketing Analytics products, including viewability tracking and engagement reporting. The approach is lightweight and web-focused, designed to provide campaign measurement and verification data to marketing teams without presuming integration into named enterprise systems.
|
Oncopeptides, Inc. IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2018 | 2018 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Oncopeptides, Inc.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Oncopeptides, Inc. Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||